REGN
Regeneron Pharmaceuticals, Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding):
keluasan pemegang -3.6% ·
aliran saham -1.3% ·
posisi baru bersih -7.4%
— formula
Distribusi luas — penurunan saham dan lebih sedikit pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 169 | -1 | 76.12M | $47.53B | +5 | −5 |
| Q1 2026 | 172 | -4 | 77.87M | $60.04B | +2 | −7 |
| Q4 2025 | 175 | 0 | 81.03M | $62.54B | +1 | — |
| Q3 2025 | 27 | -1 | 48.96M | $27.52B | — | −2 |
| Q2 2025 | 26 | +2 | 40.24M | $21.12B | +3 | −1 |
| Q1 2025 | 21 | +1 | 16.62M | $10.53B | +1 | — |
| Q4 2024 | 20 | -1 | 17.24M | $12.28B | — | −1 |
| Q3 2024 | 20 | +1 | 13.10M | $13.76B | +2 | −1 |
| Q2 2024 | 19 | — | 13.77M | $14.47B | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasif) | 9.05M | -4.0% | $5.09B | 0.1% | ▼ Trim | 2 | SEC ↗ ×7 |
| 2 | BlackRock ✦ (pasif) | 8.84M | -4.7% | $4.97B | 0.1% | ▼ Trim | 2 | SEC ↗ ×22 |
| 3 | JPMorgan Chase ✦ | 8.14M | — | $4.58B | 0.1% | n/c | 1 | SEC ↗ ×42 |
| 4 | State Street Global Advisors ✦ (pasif) | 4.69M | -2.9% | $2.64B | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 5 | Dodge & Cox ✦ | 4.55M | +18.9% | $2.56B | 1.4% | ▲ Add | 6 | SEC ↗ |
| 6 | Geode Capital Management ✦ (pasif) | 2.54M | +2.9% | $1.42B | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Capital World Investors ✦ | 2.00M | +1.6% | $1.12B | 0.2% | ▲ Add | 6 | SEC ↗ |
| 8 | Fidelity (FMR) ✦ | 1.94M | -41.8% | $1.09B | 0.1% | ▼ Trim | 2 | SEC ↗ ×4 |
| 9 | Morgan Stanley ✦ | 1.45M | — | $815.84M | 0.0% | n/c | 1 | SEC ↗ ×17 |
| 10 | Goldman Sachs Group ✦ | 952.84K | — | $535.75M | 0.1% | n/c | 1 | SEC ↗ ×6 |
| 11 | D. E. Shaw & Co. ✦ | 861.59K | +10.8% | $484.45M | 0.4% | ▲ Add | 6 | SEC ↗ ×2 |
| 12 | T. Rowe Price ✦ | 804.91K | +5.0% | $452.58M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 13 | AQR Capital Management ✦ | 721.35K | +528.7% | $405.60M | 0.3% | ▲ Add | 6 | SEC ↗ ×7 |
| 14 | Two Sigma Investments ✦ | 469.90K | -6.0% | $264.21M | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 15 | Marshall Wace ✦ | 386.88K | +61.3% | $217.53M | 0.2% | ▲ Add | 6 | SEC ↗ ×3 |
| 16 | Renaissance Technologies ✦ | 275.16K | +510.6% | $154.72M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 17 | Bridgewater Associates ✦ | 235.38K | +164.3% | $132.35M | 0.5% | ▲ Add | 6 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 230.23K | -66.2% | $129.45M | 0.1% | ▼ Trim | 6 | SEC ↗ ×2 |
| 19 | Point72 Asset Management ✦ | 201.50K | +40.8% | $113.30M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 20 | Millennium Management ✦ | 201.08K | -40.6% | $113.06M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 21 | Arrowstreet Capital ✦ | 192.58K | +3076.4% | $108.28M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 22 | Adage Capital Partners ✦ | 123.05K | +28.7% | $69.19M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 23 | Gotham Asset Management ✦ | 84.23K | +211.9% | $47.36M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 24 | ARK Investment Management ✦ | 12.14K | -3.7% | $6.83M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 25 | Wellington Management ✦ | 7.62K | -89.3% | $4.28M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 26 | Fisher Asset Management ✦ | 4.64K | +6.5% | $2.61M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 27 | GAMCO Investors ✦ | 646 | +7.3% | $363,226 | 0.0% | ▲ Add | 6 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Norges Bank | $628.15M | adalah 0.1% |
| Scion Asset Management | $7.88M | adalah 14.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1,385 pemegang, 83.52M saham, $61.43B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Director · 400 lbr · $340,000
Director · 400 lbr · $320,000
Director · 800 lbr · $640,000
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi